Overexpression and gene amplification of EGFR, HER2, and HER3 in biliary tract carcinomas, and the possibility for therapy with the HER2-targeting antibody pertuzumab
Crossref DOI link: https://doi.org/10.1007/s00535-014-0984-5
Published Online: 2014-08-12
Published Print: 2015-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kawamoto, Toru
Ishige, Kazunori
Thomas, Melanie
Yamashita-Kashima, Yoriko
Shu, Sei
Ishikura, Nobuyuki
Ariizumi, Shunichi
Yamamoto, Masakazu
Kurosaki, Kunihiko
Shoda, Junichi
Text and Data Mining valid from 2014-08-12